
Italian venture capital manager investing in technology start-ups from late seed to Series B or C

Early-growth venture fund investing in data storage and drug discovery tools, run by experienced operators

Brightstone Venture Capital manages a venture fund for companies in the early growth stage. It says it works with extraordinary entrepreneurs to build exceptional companies, and it relies on the operating experience and investment background of its partners. The firm says its partners bring about fifteen years of venture fund partnership, ten years in technology investment banking, decades of corporate board service and about a quarter century of portfolio management in technology and life sciences businesses.
The fund invests mainly in two sectors: data storage and management, and drug discovery tools and platforms. The partners have sat on the boards of companies in areas including healthcare, real estate technology, medical devices and consumer services. Their experience covers oil and gas, information technology, life sciences and consumer products, and the firm also points to founder and management experience in financial technology, cybersecurity and artificial intelligence applied to life sciences.
The firm lists a range of companies its partners have backed or helped build. VRChat operates a platform for creating social virtual reality experiences. StemoniX provides stem cell based micro-organ models that pharmaceutical and research organizations use to test drug toxicity and efficacy. BiteSquad runs an on-demand food delivery platform and was sold to Waitr. Gravie offers a health insurance platform that lets consumers choose, buy and pay for coverage in one place. Miromatrix works on biological replacement organs, and HomeSpotter made a mobile real estate search application. FlipGrid, a video platform for classrooms, was sold to Microsoft, and CodeStream, which lets developers annotate code and chat within their editor, was sold to New Relic.
Other entries include Vathys, which builds deep learning processors, and Viosera, which works to predict and block the evolution of drug resistance. Intact Therapeutics is developing a localized drug delivery platform, and Aria CV a pulmonary assist device for people with pulmonary arterial hypertension. Cryosa is developing treatments for sleep disordered breathing, Afriex runs a blockchain based mobile remittance platform, and Xplore provides a mission platform for destinations beyond low Earth orbit. The firm also highlights a storage product that it says is faster than cloud object storage yet cheaper than archive tiers.
Brightstone Venture Capital manages a venture fund aimed at early-growth stage companies. Its partners bring operating and investing backgrounds, and the firm describes its purpose as helping entrepreneurs build strong companies.
The partners' experience covers venture investing, technology investment banking, portfolio management and senior management roles. Several have held board seats at technology and life science businesses.
Entrepreneurs building technology and life science companies. Its portfolio has included AI-based revenue optimisation, a virtual reality social network and BiteSquad, a food delivery business that was sold to Waitr.
Summary written by TrustList from the business's own published information, Nov 2026.
2 images - click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Brightstone Venture Capital.
Similar listings buyers compare against this one.

Italian venture capital manager investing in technology start-ups from late seed to Series B or C

Seed and Series A investor in cyber security and business software companies across the United States

Growth equity firm partnering with established founder-led companies through long-term collaboration

Venture capital firm investing in early to growth-stage fintech companies through a network of banks

Venture capital firm investing in information technology and digital health companies in Europe and Brazil

Pre-seed and seed investor in software and Web3 startups, active since 2019

Investment bank advising fintech companies on mergers, capital raises and public listings

A fund management services provider supporting fund managers, family offices and investors worldwide
Everything here links back to the same verified catalogue. Pick your next stop.